Abstract: Antimicrobial polymers, composition including the polymers, and methods of forming and using the polymers and compositions are disclosed. The compositions have reverse thermal gelling properties and transform from a liquid to a gel—e.g., near or below body temperature, such as a skin temperature in an operating room. The polymers and compositions can be applied to a surface, such as a surface of skin proximate an incision site prior to surgery, to provide a relatively sterile area near the site.

Abstract: An implant and method for posterior sacroiliac fusion having a plate for placement across the posterior surface of the sacroiliac joint, a transverse pin to slide through the plate and transverse the joint as well as provide an aperture to receive bone graft, and a sacral screw to be inserted through the plate.

Abstract: The present invention relates to Saroglitazar free acid of Formula (IA) or its pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable esters, stereoisomers, tautomers, analogs and derivatives thereof. The present invention also provides an amorphous form of saroglitazar free acid and processes of preparation thereof. The present invention also provides pharmaceutical composition comprising an amorphous form saroglitazar magnesium.

Abstract: An implant and method for posterior sacroiliac fusion having a plate for placement across the posterior surface of the sacroiliac joint, a transverse pin to slide through the plate and transverse the joint as well as provide an aperture to receive bone graft, and a sacral screw to be inserted through the plate.

Abstract: A plate including elements for receiving threads of a fastener element such that the fastener element may be positioned close, if not flush, to a surface of the plate allowing placement of the assembly much closer to a joint than previous known methods and without interfering with the function of a joint.

Abstract: The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also provides a process for the preparation of saroglitazar. The invention further provides intermediates as well process for preparation thereof.

Abstract: The present invention relates to Saroglitazar free acid of Formula (IA) or its pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable esters, stereoisomers, tautomers, analogs and derivatives thereof. The present invention also provides an amorphous form of saroglitazar free acid and processes of preparation thereof. The present invention also provides pharmaceutical composition comprising an amorphous form saroglitazar magnesium.

Abstract: The present invention relates to an improved process for the preparation of pyrroles derivatives having hypolipidemic and hypocholesteremic activities. In particular, the invention relates to an improved process for the preparation of 2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy)phenyl)propanoate and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also relates to an improved process for the preparation of mesylate compound (A1).

Abstract: The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also provides a process for the preparation of saroglitazar. The invention further provides intermediates as well process for preparation thereof.

Abstract: A technique of encoding video frames allocates an available number of bits to different portions of the video frame. A processing unit identifies a region of interest (ROI) in a video frame, and computes a first and second complexity parameter respectively representing the change in video information in the ROI portions and non-ROI portions in the video frame relative to a reference frame. Bits are allocated to the ROI portion proportional (positive correlation) to the first complexity parameter and a ratio of the area of the ROI to the area of the frame. The remaining available bits are allocated to the non-ROI. In an embodiment, the bits are encoded according to H.264 standard.

Abstract: A technique of encoding video frames allocates an available number of bits to different portions of the video frame. A processing unit identifies a region of interest (ROI) in a video frame, and computes a first and second complexity parameter respectively representing the change in video information in the ROI portions and non-ROI portions in the video frame relative to a reference frame. Bits are allocated to the ROI portion proportional (positive correlation) to the first complexity parameter and a ratio of the area of the ROI to the area of the frame. The remaining available bits are allocated to the non-ROI. In an embodiment, the bits are encoded according to H.264 standard.